Intuitive Surgical rated Hold with 9.17% upside, driven by growth in ASC procedures and limited remanufacturing risks.

Intuitive Surgical is rated a Hold with a price target of $426.65, implying a 9.17% upside. The company's growth potential lies in untapped Ambulatory Surgery Center (ASC) procedure volume and the limited threat from remanufacturing, which currently has less than 3% penetration and approvals for only 4 of over 45 instruments. Despite trading at a premium valuation due to strong growth and high recurring revenue, the stock's upside is considered moderate. Investors should watch how the ASC market develops and remanufacturing trends evolve.